Study of the virulence of serotypes 4 and 9 of African horse sickness virus in IFNAR −/− , Balb/C and 129 Sv/Ev mice
- 1 December 2014
- journal article
- Published by Elsevier in Veterinary Microbiology
- Vol. 174 (3-4) , 322-332
Abstract
No abstract availableKeywords
Funding Information
- Belgium Federal Public Service, Health, Food Chain Safety and Environment
This publication has 30 references indexed in Scilit:
- Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisationVirus Research, 2014
- Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness VirusPLOS ONE, 2013
- NS3 of Bluetongue Virus Interferes with the Induction of Type I InterferonJournal of Virology, 2013
- Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responsesJournal of Clinical Investigation, 2013
- ‘Schmallenberg virus’ – a novel orthobunyavirus emerging in EuropeEpidemiology and Infection, 2012
- Serological survey of African horse sickness in selected districts of Jimma zone, Southwestern EthiopiaTropical Animal Health and Production, 2011
- A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse ModelPLOS ONE, 2011
- Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout miceJournal of General Virology, 2010
- Real-Time Fluorogenic Reverse Transcription Polymerase Chain Reaction Assay for Detection of African Horse Sickness VirusJournal of Veterinary Diagnostic Investigation, 2008
- Role of early cytokines, including alpha and beta interferons (IFN-α\β), in innate and adaptive immune responses to viral infectionsSeminars in Immunology, 1998